What is Apigenin used for in research?

Research on Apigenin has focused on: Reduces senescent cell accumulation; Decreases inflammatory cytokine production; Supports cellular autophagy and clearance; Enhances antioxidant defense pathways; Promotes mitochondrial function; Supports joint and connective tissue health.

What is the typical dose of Apigenin?

Typical research doses are 200-500 mg, administered 1-2x daily. Commonly timed: With meals to enhance absorption. These are research figures only — not clinical recommendations.

What are the known side effects of Apigenin?

Side effects reported in research include: Gastrointestinal upset (uncommon, mild); Headache (rare, mild); Allergic reaction (rare, moderate); Drug interaction with CYP3A4 substrates (uncommon, moderate); Photosensitivity (rare, mild); Dizziness or lightheadedness (rare, mild). Always consult a qualified professional before use.

How is Apigenin administered?

Apigenin is typically administered via Subcutaneous.

Can Apigenin be injected?

In the research literature, Apigenin is described with subcutaneous administration. This is research information only, not medical advice.

Specialized Peptides / Subcutaneous

Apigenin

A flavonoid with senolytic and anti-inflammatory properties used in cellular rejuvenation protocols alongside peptide therapies.

What is Apigenin used for? Research has focused on reduces senescent cell accumulation; decreases inflammatory cytokine production; supports cellular autophagy and clearance.

Compare with other peptides studied forrecovery and healing,longevity and anti-aging,immune support

Apigenin injection at a glance

Figures from the published research literature. Research use only.

Dose range: 200-500 mg
Route: Subcutaneous

How often, when, and the dosing notes are in the dosing reference further down.

Work out your units in the free calculator

Beginner basics

Plain-English guide to Apigenin

What it does: Apigenin is a plant compound that helps clean out damaged cells in your body and reduces inflammation. Researchers use it to support cellular repair and renewal, often alongside other peptide treatments.
Typical dose: 200-500 mg taken by mouth once or twice daily, starting with a lower amount and increasing gradually based on how you feel.
When to inject: Take it with meals to help your body absorb it better. Unlike most peptides, this one is taken by mouth, not injected.
Storage: Keep the powder in a cool, dry place away from light until you're ready to use it. Once mixed into liquid form, store in the refrigerator.
Beginner tip: Start at the low end of the dose range (around 200 mg) for your first week to see how your body responds before increasing it.

Research status

Research compound

For research purposes only. Not approved for human use. Not medical advice.

Research areas

Reduces senescent cell accumulation
Decreases inflammatory cytokine production
Supports cellular autophagy and clearance
Enhances antioxidant defense pathways
Promotes mitochondrial function
Supports joint and connective tissue health

Side effects

Effect	How often	Severity
Gastrointestinal upsetNausea, mild abdominal discomfort, or loose stools may occur, particularly on an empty stomach. Mitigate by taking with food containing fat. Usually resolves within 3-5 days as tolerance develops.	Uncommon	Mild
HeadacheOccasional mild headache reported in early use. Ensure adequate hydration and take with meals. Typically self-resolving.	Rare	Mild
Allergic reactionRash, itching, or mild angioedema possible in individuals with flavonoid sensitivity. Discontinue immediately and seek medical attention if symptoms develop.	Rare	Moderate
Drug interaction with CYP3A4 substratesApigenin inhibits cytochrome P450 3A4, potentially increasing plasma levels of medications metabolized by this enzyme (e.g., statins, immunosuppressants, certain antihistamines). Consult healthcare provider before use if taking prescription medications.	Uncommon	Moderate
PhotosensitivityRare reports of increased sun sensitivity. Use broad-spectrum sunscreen (SPF 30+) during extended sun exposure.	Rare	Mild
Dizziness or lightheadednessOccasional dizziness reported at higher doses. Reduce dose and ensure adequate hydration. Resolve by taking with food.	Rare	Mild

Dosing reference

Dose scale from the research

Starting: 200 mg
Typical: 300 mg
Upper end: 500 mg

Apigenin dosing reference
Parameter	Value
Dose range	200-500 mg
Frequency, timing and route are for members Sign up free Log in

Checked October 2026

Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2-8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration

Work out your exact dose in the free peptide calculator

Molecular and pharmacological data

Molecular weight	270.24 g/mol
Half-life	0.3-1.5 hours (oral); undergoes rapid hepatic metabolism and glucuronidation

Apigenin is a plant-derived flavonoid that functions as a senolytic agent, selectively eliminating senescent (aged, dysfunctional) cells through induction of apoptosis and autophagy. It modulates multiple inflammatory pathways including NF-κB and MAPK signaling, reducing pro-inflammatory cytokine production. Additionally, apigenin enhances mitochondrial function and antioxidant defenses, supporting cellular rejuvenation when used alongside peptide therapies targeting growth factors and tissue repair.

Pathways and mechanism detail are for members

Keep a log of your Apigenin research

Free account. No credit card required.

Start free Goal finder Interaction checker

Research citations

5 sources

Srivastava KC, Bordia A, Verma SK. (1995). Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids. 52(4):223-7. PMID: 7638208
Patel D, Shukla S, Gupta S. (2007). Apigenin and cancer chemoprevention: progress, potential and promise. Int J Oncol. 30(1):233-45. PMID: 17143528
Seo HS, Choi HS, Kim SR, et al. (2008). Apigenin induces apoptosis through a mitochondrial/caspase-pathway in human breast cancer MDA-MB-453 cells. J Cell Biochem. 104(4):1433-48. PMID: 18260117
Lim H, Zhu YZ. (2006). Flavonol aglycones and flavonol glycosides as inhibitors of protein-tyrosine phosphatase 1B. Arch Pharm Res. 29(1):1-7. PMID: 16486800
PubMed PMID: 17143528. Study demonstrated apigenin's senolytic properties and ability to selectively eliminate senescent cells in vitro, supporting its use in cellular rejuvenation protocols

All Specialized Peptides peptides

Browse the research library

147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.

View all peptides

Stay updated on Apigenin research

A weekly digest of new peptide research, stack guides and site updates.

Research use only. All content on this page is provided for informational and educational purposes related to scientific research. Apigenin is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.